Hurst; David Nigel
Patent Applications and Registrations
Patent applications and USPTO patent grants for Hurst; David Nigel.The latest application filed is for "oxadiazole derivatives active on sphingosine-1-phosphate (sip)".
- Hurst; David Nigel - Harlow GB
- Hurst; David Nigel - Essex GB
- Hurst; David Nigel - Welwyn GB
- Hurst; David Nigel - Digswell GB
| Patent | Date |
|---|---|
| Oxadiazole derivatives active on sphingosine-1-phosphate (S1P) Grant 8,222,245 - Demont , et al. July 17, 2 | 2012-07-17 |
| 1, 2, 4 -oxadiazole Compounds For The Treatment Of Autoimmune Diseases App 20100273770 - Heer; Jag Paul ; et al. | 2010-10-28 |
| Oxadiazole Derivatives Active On Sphingosine-1-phosphate (sip) App 20100273771 - Demont; Emmanuel Hubert ; et al. | 2010-10-28 |
| Compounds App 20100174065 - HEER; Jag Paul ; et al. | 2010-07-08 |
| Pyridine Compounds For The Treatment Of Prostaglandin Mediated Diseases App 20100137378 - Giblin; Gerard Martin Paul ; et al. | 2010-06-03 |
| Cyclopropyl aryl amide derivatives and uses thereof Grant 7,723,391 - Du Bois , et al. May 25, 2 | 2010-05-25 |
| Benzofuran Compounds Useful In The Treatment Of Conditions Mediated By The Action Of Pge2 At The Ep1 Receptor App 20100056527 - Eatherton; Andrew John ; et al. | 2010-03-04 |
| Indole Compounds App 20100016371 - Giblin; Gerard Martin Paul ; et al. | 2010-01-21 |
| Indole Compounds App 20090298866 - Hall; Adrian ; et al. | 2009-12-03 |
| Pyrazole Compounds As Prostaglandin Receptors Ligands App 20090239845 - Conway; Elizabeth Ann ; et al. | 2009-09-24 |
| Cyclopentene compounds App 20090227591 - Giblin; Gerard Martin Paul ; et al. | 2009-09-10 |
| Benzofuran Compounds As EP1 Receptor Antagonists App 20090099169 - Gibson; Mairi ; et al. | 2009-04-16 |
| Pyridyl Compounds App 20090099177 - Giblin; Gerard Martin Paul ; et al. | 2009-04-16 |
| Cyclopropyl aryl amide derivatives and uses thereof App 20090093525 - Bois; Daisy Joe Du ; et al. | 2009-04-09 |
| Furan Compounds Useful As Ep1 Receptor Antagonists App 20080287430 - Bit; Rino Antonio ; et al. | 2008-11-20 |
| Phenyl compounds Grant 7,446,222 - Bit , et al. November 4, 2 | 2008-11-04 |
| Cyclohexene Compounds App 20080234335 - Giblin; Gerard Martin Paul ; et al. | 2008-09-25 |
| Oxazole and Thiazole Compounds and Their Use in the Treatment of Pge2 Mediated Disorders App 20080207708 - Bit; Rino Antonio ; et al. | 2008-08-28 |
| Phenyl Compounds And Their Use In The Treatment Of Conditions Mediated By The Action Of Pge2 At The Ep1 Receptor App 20070225340 - Bit; Rino Antonio ; et al. | 2007-09-27 |
| (2-((2-alkoxy)-phenyl) -cyclopent-1enyl) aromatic carbo and heterocyclic acid and derivatives Grant 7,232,821 - Giblin , et al. June 19, 2 | 2007-06-19 |
| Heterocyclyl compounds App 20070060596 - Giblin; Gerard Martin Paul ; et al. | 2007-03-15 |
| Phenyl compounds App 20060235057 - Bit; Rino Antonio ; et al. | 2006-10-19 |
| (2-((2-alkoxy)-phenyl)-cyclopent-1enyl) aromatic carbo and heterocyclic acid and derivatives App 20050239802 - Giblin, Gerard Martin Paul ; et al. | 2005-10-27 |
| Oxamide IMPDH inhibitors Grant 6,867,299 - Broadhurst , et al. March 15, 2 | 2005-03-15 |
| Amino acid derivatives Grant 6,018,020 - Attwood , et al. January 25, 2 | 2000-01-25 |
| Peptidyl inhibitors of viral proteases Grant 5,866,684 - Attwood , et al. February 2, 1 | 1999-02-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 